( sup 3 H)TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: In vitro characterization
- Marion Merrell Dow Inc., Kansas City, MO (USA)
Binding of the new benzothiazepine calcium channel blocker, (+)-(2S,3S)-3-acetoxy-8-chloro-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2- (4- methoxyphenyl)-1,5-benzothiazepine-4-(5H)-one maleate, (3H)TA-3090, was characterized and its specificity for rat myocardial benzothiazepine receptors described. Scatchard plots and nonlinear regression analysis of specific (3H)TA-3090 binding best fit a one-site binding model (Kd = 8.8 +/- 2.7 nM, Bmax = 132 +/- 38 fmol/mg protein). Kinetically derived affinity constants were in close agreement (Kd = 7.86 nM) with those obtained from analysis of equilibrium binding data. In comparison, under identical conditions (3H)diltiazem exhibited a Kd of 38 nM and Bmax, 106 fmol/mg protein. Specific binding was saturable, reversible and stereoselective (d-cis-TA-3090 Ki = 14 nM; 1-cis-TA-3090 Ki = 2700 nM). Competitions for (3H)TA-3090 binding were conducted with nifedipine, propranolol, prazosin, quinuclidinyl benzilate, verapamil and yohimbine. Only the calcium channel blockers nifedipine and verapamil inhibited specific (3H)TA-3090 binding. Nifedipine could maximally inhibit only 52% of specifically bound (3H)TA-3090 at 10 microM. In contrast, however, 10 microM verapamil completely inhibited specific radioligand binding (Ki = 93 +/- 28 nM) but with six times less efficacy than TA-3090. Thus, these data demonstrate that (3H)TA-3090 is a potent radioligand selective for the benzothiazepine binding site and is consistent with the hypothesis that (3H)TA-3090 interacts with a myocardial benzothiazepine receptor site.
- OSTI ID:
- 6727859
- Journal Information:
- Journal of Pharmacology and Experimental Therapeutics; (USA), Vol. 253:2; ISSN 0022-3565
- Country of Publication:
- United States
- Language:
- English
Similar Records
Evidence for leukotriene D4 receptors in guinea pig left atria
Synthesis of a tritium-labeled indolidan analogue and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites
Related Subjects
PORINS
BIOCHEMICAL REACTION KINETICS
CHEMICAL COMPOSITION
ENZYME INHIBITORS
IN VITRO
MATHEMATICAL MODELS
MYOCARDIUM
RATS
RECEPTORS
REGRESSION ANALYSIS
TISSUE CULTURES
TRACER TECHNIQUES
TRITIUM COMPOUNDS
ANIMALS
BODY
CARDIOVASCULAR SYSTEM
HEART
HYDROGEN COMPOUNDS
ISOTOPE APPLICATIONS
KINETICS
MAMMALS
MATHEMATICS
MEMBRANE PROTEINS
MUSCLES
ORGANIC COMPOUNDS
ORGANS
PROTEINS
REACTION KINETICS
RODENTS
STATISTICS
VERTEBRATES
550201* - Biochemistry- Tracer Techniques